IBDEI1XN ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32782,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,32783,0)
 ;;=Z85.828^^128^1636^53
 ;;^UTILITY(U,$J,358.3,32783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32783,1,3,0)
 ;;=3^Personal Hx of Malig Neop Skin
 ;;^UTILITY(U,$J,358.3,32783,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,32783,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,32784,0)
 ;;=Z65.8^^128^1636^58
 ;;^UTILITY(U,$J,358.3,32784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32784,1,3,0)
 ;;=3^Personal Hx of Psychosocial Circumstance Problems
 ;;^UTILITY(U,$J,358.3,32784,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,32784,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,32785,0)
 ;;=Z86.718^^128^1636^61
 ;;^UTILITY(U,$J,358.3,32785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32785,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis & Embolism
 ;;^UTILITY(U,$J,358.3,32785,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,32785,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,32786,0)
 ;;=Z86.73^^128^1636^60
 ;;^UTILITY(U,$J,358.3,32786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32786,1,3,0)
 ;;=3^Personal Hx of TIA
 ;;^UTILITY(U,$J,358.3,32786,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,32786,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,32787,0)
 ;;=Z86.79^^128^1636^43
 ;;^UTILITY(U,$J,358.3,32787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32787,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,32787,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,32787,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,32788,0)
 ;;=Z87.11^^128^1636^57
 ;;^UTILITY(U,$J,358.3,32788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32788,1,3,0)
 ;;=3^Personal Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,32788,1,4,0)
 ;;=4^Z87.11
 ;;^UTILITY(U,$J,358.3,32788,2)
 ;;=^5063482
 ;;^UTILITY(U,$J,358.3,32789,0)
 ;;=Z86.010^^128^1636^44
 ;;^UTILITY(U,$J,358.3,32789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32789,1,3,0)
 ;;=3^Personal Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,32789,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,32789,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,32790,0)
 ;;=Z87.39^^128^1636^54
 ;;^UTILITY(U,$J,358.3,32790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32790,1,3,0)
 ;;=3^Personal Hx of Musculoskeletal System Diseases
 ;;^UTILITY(U,$J,358.3,32790,1,4,0)
 ;;=4^Z87.39
 ;;^UTILITY(U,$J,358.3,32790,2)
 ;;=^5063488
 ;;^UTILITY(U,$J,358.3,32791,0)
 ;;=Z92.3^^128^1636^48
 ;;^UTILITY(U,$J,358.3,32791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32791,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,32791,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,32791,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,32792,0)
 ;;=Z87.820^^128^1636^59
 ;;^UTILITY(U,$J,358.3,32792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32792,1,3,0)
 ;;=3^Personal Hx of TBI
 ;;^UTILITY(U,$J,358.3,32792,1,4,0)
 ;;=4^Z87.820
 ;;^UTILITY(U,$J,358.3,32792,2)
 ;;=^5063514
 ;;^UTILITY(U,$J,358.3,32793,0)
 ;;=Z87.891^^128^1636^55
 ;;^UTILITY(U,$J,358.3,32793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32793,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,32793,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,32793,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,32794,0)
 ;;=Z77.090^^128^1636^45
 ;;^UTILITY(U,$J,358.3,32794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32794,1,3,0)
 ;;=3^Personal Hx of Contact With & Exposure to Asbestos
 ;;^UTILITY(U,$J,358.3,32794,1,4,0)
 ;;=4^Z77.090
 ;;^UTILITY(U,$J,358.3,32794,2)
 ;;=^5063312
 ;;^UTILITY(U,$J,358.3,32795,0)
 ;;=Z57.8^^128^1636^56
 ;;^UTILITY(U,$J,358.3,32795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32795,1,3,0)
 ;;=3^Personal Hx of Occupational Exposure to Other Risk Factors
